Pensions & Investments Logo
ETF Exchange > GNOM ETF

GNOM - ETF Fact Sheet

Global X Genomics & Biotechnology ETF - USD

Fund Identification

Ticker

GNOM

ISIN

US37960A2143

Main Metrics

Price

$55.03

Expense Ratio

0.5%

AuM

$84.45M

Tracking Difference

-0.58%

Ratings

Trackinsight rating

Official Investment Strategy

The Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.

GNOM's historical prices, performance, and flows

051015%
1m returns
10%
1m flows
$18M
* Net total returns
All data as of 17 July 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all GNOM data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

GNOM's characteristics

Manager

Manager statistics

516 funds, $161.84Bn in AUM

Benchmark

Solactive Genomics Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
GNOM's exposure

Countries

USA
82.83%
Other
17.17%

Sectors

Healthcare
99.71%

Top 5 holdings

Guardant Health, Inc.
5.59%
Illumina, Inc.
4.82%
Natera, Inc.
4.15%
BioMarin Pharmaceutical, Inc.
4.09%
Arrowhead Pharmaceuticals, Inc.
4.07%
Total holdings
50
Total weight of top 5
22.73%
15%